Study of Varespladib in Patients Hospitalized With Severe COVID-19

Clinical trial NCT04969991 · TERMINATED

Trial details

NCT number: NCT04969991
Sponsor: Ophirex, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronavirus Disease 2019 Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2

Start date: 2021-06-30
Primary completion: 2022-02-11
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.